article_seq==222$ sen_num==6$ article_text==[CLS] temporally following this growth arrest  the cells develop a senescence morphology and express senescence associated  [beta galactosidase]   [sa beta gal]   [SEP][CLS] levels of  [pNUM]  [inkNUMa]  and  [pNUM]  [kipNUM]  rise in hucs during progressive passages  whereas only  [pNUM] increases in hpec cultures  [SEP][CLS] the induced expression of  [pNUM]  similar to  [pNUM]  produces a senescent like phenotype  [SEP][CLS]  [prb]   [cyclin d]   [pNUM]  [inkNUMd]  and  [pNUM]  [kipNUM]  decrease in both cell types  [SEP][CLS] we find that  [pNUM]   [pNUM]  [cipNUM]  and  [pNUM]  [inkNUMb]  are transiently elevated in hpecs and hucs at the pre senescent growth arrest  then return to low proliferating levels at terminal senescence  [SEP][CLS] analysis of  [pNUM]   [pNUM]  [cipNUM]    [pNUM]  [inkNUMb]    [pNUM]  [inkNUMa]   and  [pNUM]  [kipNUM]  reveals altered expression in immortalized  non tumorigenic hpvNUM eNUM and eNUM prostate lines and in tumorigenic prostate cancer cells  [SEP]$ protein_info=={beta-galactosidase;[0]}{sa-beta-gal;[1]}{p16;[2, 6, 8, 25]}{ink4a;[3, 26]}{p57;[4, 7, 27]}{kip2;[5, 28]}{prb;[9]}{cyclin d;[10]}{p19;[11]}{ink4d;[12]}{p27;[13]}{kip1;[14]}{p53;[15, 20]}{p21;[16, 21]}{cip1;[17, 22]}{p15;[18, 23]}{ink4b;[19, 24]}$ pairs_info=={beta-galactosidase;SA-beta-gal;false;1;0}{p16;INK4a;false;3;0}{p16;p57;false;4;0}{p16;KIP2;false;3;0}{INK4a;p57;false;2;0}{INK4a;KIP2;false;2;0}{p57;KIP2;false;2;0}{pRB;cyclin D;false;1;0}{pRB;p19;false;1;0}{pRB;INK4d;false;1;0}{pRB;p27;false;1;0}{pRB;KIP1;false;1;0}{cyclin D;p19;false;1;0}{cyclin D;INK4d;false;1;0}{cyclin D;p27;false;1;0}{cyclin D;KIP1;false;1;0}{p19;INK4d;false;1;0}{p19;p27;false;1;0}{p19;KIP1;false;1;0}{INK4d;p27;false;1;0}{INK4d;KIP1;false;1;0}{p27;KIP1;false;1;0}{p53;p21;false;2;0}{p53;CIP1;false;2;0}{p53;p15;false;2;0}{p53;INK4b;false;2;0}{p21;CIP1;false;2;0}{p21;p15;false;2;0}{p21;INK4b;false;2;0}{CIP1;p15;false;2;0}{CIP1;INK4b;false;2;0}{p15;INK4b;false;2;0}{p53;p16;false;1;0}{p53;INK4a;false;1;0}{p53;p57;false;1;0}{p53;KIP2;false;1;0}{p21;p16;false;1;0}{p21;INK4a;false;1;0}{p21;p57;false;1;0}{p21;KIP2;false;1;0}{CIP1;p16;false;1;0}{CIP1;INK4a;false;1;0}{CIP1;p57;false;1;0}{CIP1;KIP2;false;1;0}{p15;p16;false;1;0}{p15;INK4a;false;1;0}{p15;p57;false;1;0}{p15;KIP2;false;1;0}{INK4b;p16;false;1;0}{INK4b;INK4a;false;1;0}{INK4b;p57;false;1;0}{INK4b;KIP2;false;1;0}$
article_seq==212$ sen_num==6$ article_text==[CLS] positive inotropic responses mediated by endothelin  [et a ] and  [et b ] receptors in human myocardial trabeculae  [SEP][CLS] the aim of the present study was to determine possible inotropic effects mediated by endothelin  [et a ] and  [et b ] receptors in human myocardial trabeculae from the right atrium and the left ventricle  [SEP][CLS]  [endothelin NUM]   [et NUM]  and  [et NUM] had a strong positive inotropic effect in all trabeculae  [SEP][CLS]  [et NUM] was significantly more potent than  [et NUM] in both atrial  p   NUM NUM  and ventricular  p   NUM NUM  trabeculae  [SEP][CLS] preincubation with the  [et a  receptor] antagonist frNUM  NUM microm  decreased significantly  p   NUM NUM  the potency of  [et  i] in both atrial and ventricular trabeculae  without any significant changes in emax  maximum effect obtained with an agonist   [SEP][CLS] these results suggest that both  [et a ] and  [et b ] receptors mediate positive inotropic responses at both the atrial and ventricular level in the human heart  [SEP]$ protein_info=={et(a);[0, 2, 11]}{et(b);[1, 3, 12]}{endothelin-1;[4]}{et-1;[5, 7]}{et-3;[6, 8]}{et(a) receptor;[9]}{et- i;[10]}$ pairs_info=={ET(A);ET(B);false;3;0}{Endothelin-1;ET-1;false;1;0}{Endothelin-1;ET-3;false;1;0}{ET-1;ET-3;false;2;0}{ET(A) receptor;ET- I;false;1;0}$
article_seq==48$ sen_num==2$ article_text==[CLS] apoptotic proteins   [pNUM] and  [c myc] related pathways  [SEP][CLS]  [c myc] and  [pNUM] are two proteins that have critical roles in the regulation of apoptosis and the cell cycle  [SEP]$ protein_info=={p53;[0, 3]}{c-myc;[1, 2]}$ pairs_info=={p53;c-myc;false;2;0}$
article_seq==136$ sen_num==3$ article_text==[CLS] a comparative study of  [e cadherin] and  [stromelysin NUM] expression in de novo and ex adenoma carcinoma of the colorectum  [SEP][CLS] the purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule   [e cadherin]  and protease   [stromelysin NUM]   [st NUM]   expression in groups of de novo  n NUM  and ex adenoma  n NUM  lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression  [SEP][CLS] the rates of extensive  [st NUM] expression and decreased  [e cadherin] expression were significantly higher in the de novo group  p NUM NUM and NUM NUM  respectively   [SEP]$ protein_info=={e-cadherin;[0, 2, 6]}{stromelysin-3;[1, 3]}{st-3;[4, 5]}$ pairs_info=={E-cadherin;stromelysin-3;false;2;0}{E-cadherin;ST-3;false;2;0}{stromelysin-3;ST-3;false;1;0}$
article_seq==89$ sen_num==2$ article_text==[CLS] background  to elucidate the relationship between the expression of epidermal growth factor receptor family members   [erbb NUM]  neu  [erbb NUM]   [erbb NUM]  and  [erbb NUM]  and tumor recurrence  [SEP][CLS] results  using cox univariate analysis  we determined that angiolymphatic tumor emboli and non well differentiated tumor cells were two significant conventional pathologic predictors of tumor recurrence  and that  [erbb NUM] and  [erbb NUM] were also significant predictors  [SEP]$ protein_info=={erbb-1;[0, 4]}{erbb-2;[1]}{erbb-3;[2, 5]}{erbb-4;[3]}$ pairs_info=={ErbB-1;ErbB-2;false;1;0}{ErbB-1;ErbB-3;false;2;0}{ErbB-1;ErbB-4;false;1;0}{ErbB-2;ErbB-3;false;1;0}{ErbB-2;ErbB-4;false;1;0}{ErbB-3;ErbB-4;false;1;0}$
article_seq==94$ sen_num==2$ article_text==[CLS] we performed cell free in vitro infection of primary bone marrow derived  [cdNUM]  cells using semi purified hhvNUM and a mature  [il NUM] dependent t cell line  kit NUM  using highly concentrated viral stocks prepared from an infectious molecular clone of htlv NUM  [SEP][CLS] of these NUM   [interferon regulatory factor NUM]   [irfNUM]    [cyclin bNUM]  tbp associated factor  eukaryotic elongation factor and  [pim NUM] were up regulated more than NUM NUM fold  [SEP]$ protein_info=={cd34;[0]}{il-2;[1]}{interferon regulatory factor 4;[2]}{irf4;[3]}{cyclin b2;[4]}{pim 2;[5]}$ pairs_info=={CD34;IL-2;false;1;0}{interferon regulatory factor 4;IRF4;false;1;0}{interferon regulatory factor 4;cyclin B2;false;1;0}{interferon regulatory factor 4;pim 2;false;1;0}{IRF4;cyclin B2;false;1;0}{IRF4;pim 2;false;1;0}{cyclin B2;pim 2;false;1;0}$
article_seq==44$ sen_num==1$ article_text==[CLS] several genes are involved in this process  and two have been the focus of recent interest  the  [natural resistance associated protein]   [nrampNUM]  gene and the genes coding for the  [vitamin d receptor]  [SEP]$ protein_info=={natural resistance-associated protein;[0]}{nramp1;[1]}{vitamin d receptor;[2]}$ pairs_info=={natural resistance-associated protein;NRAMP1;false;1;0}{natural resistance-associated protein;vitamin D receptor;false;1;0}{NRAMP1;vitamin D receptor;false;1;0}$
article_seq==41$ sen_num==1$ article_text==[CLS] many of the same signaling molecules  including  [protein kinase c]   [pkc]    [tyrosine kinase  phosphatidylinositol NUM kinase]   [pNUM k]   and protein phosphatase  regulate the transporters for different neurotransmitters  [SEP]$ protein_info=={protein kinase c;[0]}{pkc;[1]}{tyrosine kinase, phosphatidylinositol 3-kinase;[2]}{p13-k;[3]}$ pairs_info=={protein kinase C;PKC;false;1;0}{protein kinase C;tyrosine kinase, phosphatidylinositol 3-kinase;false;1;0}{protein kinase C;P13-K;false;1;0}{PKC;tyrosine kinase, phosphatidylinositol 3-kinase;false;1;0}{PKC;P13-K;false;1;0}{tyrosine kinase, phosphatidylinositol 3-kinase;P13-K;false;1;0}$
article_seq==74$ sen_num==1$ article_text==[CLS] comparison of messenger rna gene expression of extracellular matrix proteins   [procollagen i]   [collagenase]   [elastin]   [hyaluronic acid synthase NUM]   [hyaluronidase]   [fibronectin]   [cdNUM]   [fibromodulin]  and  [decorin]  across cell passages  NUM  NUM  NUM  NUM  NUM  and NUM fornormal laminapropria and NUM  NUM  NUM  NUM  and NUM for tracheal scar  revealed varied growth patterns  [SEP]$ protein_info=={procollagen i;[0]}{collagenase;[1]}{elastin;[2]}{hyaluronic acid synthase 2;[3]}{hyaluronidase;[4]}{fibronectin;[5]}{cd44;[6]}{fibromodulin;[7]}{decorin;[8]}$ pairs_info=={procollagen I;collagenase;false;1;0}{procollagen I;elastin;false;1;0}{procollagen I;hyaluronic acid synthase 2;false;1;0}{procollagen I;hyaluronidase;false;1;0}{procollagen I;fibronectin;false;1;0}{procollagen I;cd44;false;1;0}{procollagen I;fibromodulin;false;1;0}{procollagen I;decorin;false;1;0}{collagenase;elastin;false;1;0}{collagenase;hyaluronic acid synthase 2;false;1;0}{collagenase;hyaluronidase;false;1;0}{collagenase;fibronectin;false;1;0}{collagenase;cd44;false;1;0}{collagenase;fibromodulin;false;1;0}{collagenase;decorin;false;1;0}{elastin;hyaluronic acid synthase 2;false;1;0}{elastin;hyaluronidase;false;1;0}{elastin;fibronectin;false;1;0}{elastin;cd44;false;1;0}{elastin;fibromodulin;false;1;0}{elastin;decorin;false;1;0}{hyaluronic acid synthase 2;hyaluronidase;false;1;0}{hyaluronic acid synthase 2;fibronectin;false;1;0}{hyaluronic acid synthase 2;cd44;false;1;0}{hyaluronic acid synthase 2;fibromodulin;false;1;0}{hyaluronic acid synthase 2;decorin;false;1;0}{hyaluronidase;fibronectin;false;1;0}{hyaluronidase;cd44;false;1;0}{hyaluronidase;fibromodulin;false;1;0}{hyaluronidase;decorin;false;1;0}{fibronectin;cd44;false;1;0}{fibronectin;fibromodulin;false;1;0}{fibronectin;decorin;false;1;0}{cd44;fibromodulin;false;1;0}{cd44;decorin;false;1;0}{fibromodulin;decorin;false;1;0}$
article_seq==182$ sen_num==5$ article_text==[CLS] we have identified a new tnf related ligand  designated human  [gitr] ligand   [hgitrl]   and its human receptor   [hgitr]   an ortholog of the recently discovered murine glucocorticoid induced tnfr related   [mgitr]  protein  NUM   [SEP][CLS] the  [hgitrl] gene mapped to chromosome NUMqNUM  near the gene for the tnf homolog  [fas]  [cdNUM ligand]  NUM   [SEP][CLS] cotransfection of  [hgitrl] and  [hgitr] in embryonic kidney NUM cells activated the anti apoptotic transcription factor  [nf kappab]  via a pathway that appeared to involve  [tnfr associated factor NUM]   [trafNUM]   NUM  and  [nf kappab] inducing kinase   [nik]   NUM   [SEP][CLS] cotransfection of  [hgitrl] and  [hgitr] in jurkat t leukemia cells inhibited antigen receptor induced cell death  [SEP][CLS] thus   [hgitrl] and  [hgitr] may modulate t lymphocyte survival in peripheral tissues  [SEP]$ protein_info=={gitr;[0]}{hgitrl;[1, 4, 7, 14, 16]}{hgitr;[2, 8, 15, 17]}{mgitr;[3]}{fas;[5]}{cd95 ligand;[6]}{nf-kappab;[9, 12]}{tnfr-associated factor 2;[10]}{traf2;[11]}{nik;[13]}$ pairs_info=={GITR;hGITRL;true;0;1}{GITR;hGITR;false;1;0}{GITR;mGITR;false;1;0}{hGITRL;hGITR;true;3;1}{hGITRL;mGITR;false;1;0}{hGITR;mGITR;false;1;0}{hGITRL;Fas;false;1;0}{hGITRL;CD95 ligand;false;1;0}{Fas;CD95 ligand;false;1;0}{hGITRL;NF-kappaB;false;2;0}{hGITRL;TNFR-associated factor 2;false;1;0}{hGITRL;TRAF2;false;1;0}{hGITRL;NIK;false;1;0}{hGITR;NF-kappaB;false;2;0}{hGITR;TNFR-associated factor 2;false;1;0}{hGITR;TRAF2;false;1;0}{hGITR;NIK;false;1;0}{NF-kappaB;TNFR-associated factor 2;false;2;0}{NF-kappaB;TRAF2;false;2;0}{NF-kappaB;NIK;false;2;0}{TNFR-associated factor 2;TRAF2;false;1;0}{TNFR-associated factor 2;NIK;false;1;0}{TRAF2;NIK;false;1;0}$
article_seq==222$ sen_num==7$ article_text==[CLS] a newly identified member of tumor necrosis factor receptor superfamily   [trNUM]  suppresses  [light] mediated apoptosis  [SEP][CLS]  [trNUM]   [decoy receptor NUM]   [dcrNUM]   is a new member of the tumor necrosis factor receptor  tnfr  family  [SEP][CLS] here  we demonstrate that  [trNUM] specifically binds two cellular ligands   [light]  herpes virus entry mediator   [hvem]  l  and  [fas ligand]   [fasl]  [cdNUMl]   [SEP][CLS]  [trNUM] inhibited  [light] induced cytotoxicity in htNUM cells  [SEP][CLS] it has been shown that  [light] triggers apoptosis of various tumor cells including htNUM cells that express both  [lymphotoxin beta] receptor   [ltbetar]  and  [hvem]  [trNUM] receptors  [SEP][CLS] our data suggest that  [trNUM] inhibits the interactions of  [light] with  [hvem]  [trNUM] and  [ltbetar]  thereby suppressing  [light]  mediated htNUM cell death  [SEP][CLS] thus   [trNUM] may play a regulatory role for suppressing in  [fasl]  and  [light] mediated cell death  [SEP]$ protein_info=={tr6;[0, 2, 5, 11, 18, 24]}{light;[1, 6, 12, 13, 19, 23, 26]}{decoy receptor 3;[3]}{dcr3;[4]}{hvem;[7, 16, 20]}{fas ligand;[8]}{fasl;[9, 25]}{cd95l;[10]}{lymphotoxin beta;[14]}{ltbetar;[15, 22]}{tr2;[17, 21]}$ pairs_info=={TR6;LIGHT;true;5;1}{TR6;decoy receptor 3;false;1;0}{TR6;DcR3;false;1;0}{decoy receptor 3;DcR3;false;1;0}{TR6;HVEM;false;2;0}{TR6;Fas ligand;true;0;1}{TR6;FasL;true;1;1}{TR6;CD95L;true;0;1}{LIGHT;HVEM;true;3;1}{LIGHT;Fas ligand;false;1;0}{LIGHT;FasL;false;2;0}{LIGHT;CD95L;false;1;0}{HVEM;Fas ligand;false;1;0}{HVEM;FasL;false;1;0}{HVEM;CD95L;false;1;0}{Fas ligand;FasL;false;1;0}{Fas ligand;CD95L;false;1;0}{FasL;CD95L;false;1;0}{LIGHT;lymphotoxin beta;false;1;0}{LIGHT;LTbetaR;true;2;1}{LIGHT;TR2;true;2;1}{lymphotoxin beta;LTbetaR;true;0;1}{lymphotoxin beta;HVEM;false;1;0}{lymphotoxin beta;TR2;false;1;0}{LTbetaR;HVEM;false;2;0}{LTbetaR;TR2;false;2;0}{HVEM;TR2;false;2;0}{TR6;TR2;false;1;0}{TR6;LTbetaR;false;1;0}$
article_seq==98$ sen_num==3$ article_text==[CLS]  [presenilin NUM]   [psNUM]  mutations account for the majority of early onset dominant cases of familial alzheimer s disease  [SEP][CLS] we report an interaction between the human  [psNUM] or  [psNUM] hydrophilic loop and  [rabNUM]  a small gtpase belonging to the ras related superfamily  [SEP][CLS] interaction domains were mapped to codons NUM NUM for  [psNUM] and to codons NUM NUM for  [rabNUM]  a region including the fourth gtp binding domain  [SEP]$ protein_info=={presenilin 1;[0]}{ps1;[1, 2, 5]}{ps2;[3]}{rab11;[4, 6]}$ pairs_info=={Presenilin 1;PS1;false;1;0}{PS1;PS2;false;1;0}{PS1;Rab11;true;0;2}{PS2;Rab11;true;0;1}$
article_seq==317$ sen_num==9$ article_text==[CLS] molecular cloning of a novel human cc chemokine   [eotaxin NUM]  that is a functional ligand of  [cc chemokine receptor NUM]  [SEP][CLS] previously  we mapped the novel cc chemokine  [myeloid progenitor inhibitory factor NUM]   [mpif NUM]   [eotaxin NUM] to chromosome NUMqNUM NUM  nomiyama  h   osborne  l  r   imai  t   kusuda  j   miura  r   tsui  l  c   and yoshie  o   NUM  genomics NUM  NUM NUM   [SEP][CLS] prompted by this hypothesis  we analyzed the genomic region containing the gene for  [mpif NUM]  [eotaxin NUM]   [scyaNUM]  and have identified a novel cc chemokine termed  [eotaxin NUM]  [SEP][CLS] the genes for  [mpif NUM]  [eotaxin NUM]   [scyaNUM]  and  [eotaxin NUM]   [scyaNUM]  are localized within a region of approximately NUM kilobases  [SEP][CLS]  [eotaxin NUM] induced transient calcium mobilization specifically in  [cc chemokine receptor NUM]   [ccrNUM]  expressing lNUM NUM cells with an ec NUM  of NUM nm  [SEP][CLS]  [eotaxin NUM] competed the binding of  NUM  [i eotaxin] to  [ccrNUM] expressing lNUM NUM cells with an ic NUM  of NUM nm  [SEP][CLS] collectively   [eotaxin NUM] is yet another functional ligand for  [ccrNUM]  [SEP][CLS] the potency of  [eotaxin NUM] as a  [ccrNUM] ligand seems  however  to be approximately NUM fold less than that of  [eotaxin]  [SEP][CLS] identification of  [eotaxin NUM] will further promote our understanding of the control of eosinophil trafficking and other  [ccrNUM] mediated biological phenomena  [SEP]$ protein_info=={eotaxin-3;[0, 8, 12, 14, 17, 20, 22, 25]}{cc chemokine receptor 3;[1, 15]}{myeloid progenitor inhibitory factor 2;[2]}{mpif-2;[3, 5, 9]}{eotaxin-2;[4, 6, 10]}{scya24;[7, 11]}{scya26;[13]}{ccr3;[16, 19, 21, 23, 26]}{i-eotaxin;[18]}{eotaxin;[24]}$ pairs_info=={Eotaxin-3;CC chemokine receptor 3;true;1;1}{myeloid progenitor inhibitory factor 2;MPIF-2;false;1;0}{myeloid progenitor inhibitory factor 2;eotaxin-2;false;1;0}{MPIF-2;eotaxin-2;false;3;0}{MPIF-2;SCYA24;false;2;0}{MPIF-2;eotaxin-3;false;2;0}{eotaxin-2;SCYA24;false;2;0}{eotaxin-2;eotaxin-3;false;2;0}{SCYA24;eotaxin-3;false;2;0}{MPIF-2;SCYA26;false;1;0}{eotaxin-2;SCYA26;false;1;0}{SCYA24;SCYA26;false;1;0}{eotaxin-3;SCYA26;false;1;0}{Eotaxin-3;CCR3;true;2;3}{CC chemokine receptor 3;CCR3;false;1;0}{Eotaxin-3;I-eotaxin;false;1;0}{I-eotaxin;CCR3;true;0;1}{eotaxin-3;eotaxin;false;1;0}{CCR3;eotaxin;true;0;1}$
article_seq==202$ sen_num==5$ article_text==[CLS] a mutant form of human  [interferon gamma]   [ifn gamma scNUM]  that binds one  [ifn gamma receptor alpha chain]   [ifn gamma r alpha]  has been designed and characterized  [SEP][CLS] isothermal titration calorimetry shows that  [ifn gamma scNUM] forms a NUM NUM complex with its high affinity receptor   [ifn gamma r alpha]  with an affinity of NUM     NUM  nm  [SEP][CLS] the ab loops of  [ifn gamma scNUM] adopt conformations similar to the ordered loops of  [ifn gamma] observed in the crystal structure of the  [ifn gamma]  [ifn gamma r alpha] complex  [SEP][CLS] despite binding to only one  [ifn gamma r alpha]   [ifn gamma scNUM] is biologically active in cell proliferation  mhc class i induction  and anti viral assays  [SEP][CLS] this suggests that one domain of  [ifn gamma] is sufficient to recruit  [ifn gamma r alpha] and  [ifn gamma r beta] into a complex competent for eliciting biological activity  [SEP]$ protein_info=={interferon-gamma;[0]}{ifn-gamma sc1;[1, 4, 6, 11]}{ifn-gamma receptor alpha chain;[2]}{ifn-gamma r alpha;[3, 5, 9, 10, 13]}{ifn-gamma;[7, 8, 12]}{ifn-gamma r beta;[14]}$ pairs_info=={interferon-gamma;IFN-gamma SC1;false;1;0}{interferon-gamma;IFN-gamma receptor alpha chain;false;1;0}{interferon-gamma;IFN-gamma R alpha;false;1;0}{IFN-gamma SC1;IFN-gamma receptor alpha chain;true;0;1}{IFN-gamma SC1;IFN-gamma R alpha;true;1;3}{IFN-gamma receptor alpha chain;IFN-gamma R alpha;false;1;0}{IFN-gamma SC1;IFN-gamma;false;2;0}{IFN-gamma;IFN-gamma R alpha;true;1;2}{IFN-gamma;IFN-gamma R beta;true;0;1}{IFN-gamma R alpha;IFN-gamma R beta;false;1;0}$
article_seq==236$ sen_num==8$ article_text==[CLS] human  [cc chemokine liver expressed chemokine]  [cclNUM] is a functional ligand for  [ccrNUM]   [ccrNUM] and  [ccrNUM]  and constitutively expressed by hepatocytes  [SEP][CLS]  [liver expressed chemokine]   [lec]   [cclNUM] is a human cc chemokine selectively expressed in the liver  [SEP][CLS] at relatively high concentrations   [lec] induced calcium mobilization and chemotaxis via  [ccrNUM] and  [ccrNUM]  [SEP][CLS]  [lec] also induced calcium mobilization  but marginal chemotaxis via  [ccrNUM]  [SEP][CLS] consistently   [lec] was found to bind to  [ccrNUM]   [ccrNUM] and  [ccrNUM] with relatively low affinities  [SEP][CLS] the binding of  [lec] to  [ccrNUM] was much less significant  [SEP][CLS] in spite of its binding to  [ccrNUM]   [lec] was unable to inhibit infection of an rNUM type hiv NUM to activated human peripheral blood mononuclear cells even at high concentrations  [SEP][CLS] taken together   [lec] is a new low affinity functional ligand for  [ccrNUM]   [ccrNUM] and  [ccrNUM]  and is constitutively expressed by liver parenchymal cells  [SEP]$ protein_info=={cc chemokine liver-expressed chemokine;[0]}{ccl16;[1, 7]}{ccr1;[2, 9, 14, 22]}{ccr2;[3, 10, 15, 23]}{ccr5;[4, 12, 16, 19, 24]}{liver-expressed chemokine;[5]}{lec;[6, 8, 11, 13, 17, 20, 21]}{ccr8;[18]}$ pairs_info=={CC chemokine liver-expressed chemokine;CCL16;false;1;0}{CC chemokine liver-expressed chemokine;CCR1;true;0;1}{CC chemokine liver-expressed chemokine;CCR2;true;0;1}{CC chemokine liver-expressed chemokine;CCR5;true;0;1}{CCL16;CCR1;true;0;1}{CCL16;CCR2;true;0;1}{CCL16;CCR5;true;0;1}{CCR1;CCR2;false;4;0}{CCR1;CCR5;false;3;0}{CCR2;CCR5;false;3;0}{Liver-expressed chemokine;LEC;false;1;0}{Liver-expressed chemokine;CCL16;false;1;0}{LEC;CCL16;false;1;0}{LEC;CCR1;true;0;3}{LEC;CCR2;true;0;3}{LEC;CCR5;true;0;4}{LEC;CCR8;true;0;1}$
article_seq==39$ sen_num==1$ article_text==[CLS] the crystal structure of the homodimeric  [bb isoform of human recombinant platelet derived growth factor]   [pdgf bb]  has been determined by x ray analysis to NUM NUM a resolution  [SEP]$ protein_info=={bb isoform of human recombinant platelet-derived growth factor;[0]}{pdgf-bb;[1]}$ pairs_info=={BB isoform of human recombinant platelet-derived growth factor;PDGF-BB;false;1;0}$
article_seq==189$ sen_num==6$ article_text==[CLS] human  [cyclin e]  a new cyclin that interacts with two members of the  [cdcNUM] gene family  [SEP][CLS]  [cyclin e] showed genetic interactions with the  [cdcNUM] gene  suggesting that it functioned at start by interacting with the  [cdcNUM] protein  [SEP][CLS] two human genes were identified that could interact with  [cyclin e] to perform start in yeast containing a  [cdcNUM] mutation  [SEP][CLS] one was  [cdcNUM] hs  and the second was the human homolog of xenopus  [cdkNUM]  [SEP][CLS]  [cyclin e] produced in e  coli bound and activated the  [cdcNUM] protein in extracts from human gNUM cells  and antibodies against  [cyclin e] immunoprecipitated a histone hNUM kinase from hela cells  [SEP][CLS] the interactions between  [cyclin e] and  [cdcNUM]  or  [cdkNUM]  may be important at the gNUM to s transition in human cells  [SEP]$ protein_info=={cyclin e;[0, 2, 5, 9, 11, 12]}{cdc2;[1, 7, 10, 13]}{cdc28;[3, 4, 6]}{cdk2;[8, 14]}$ pairs_info=={cyclin E;CDC2;true;2;2}{Cyclin E;CDC28;true;1;2}{CDC2;CDK2;false;2;0}{cyclin E;CDK2;true;0;1}$
article_seq==206$ sen_num==5$ article_text==[CLS] a cellular protein that competes with  [svNUM t antigen] for binding to the  [retinoblastoma] gene product  [SEP][CLS] tumour suppressor genes  such as the human  [retinoblastoma susceptibility gene]   [rb]   are widely recognized as being vital in the control of cell growth and tumour formation  [SEP][CLS] we report here the identification of one such human cellular  [rb] associated protein of relative molecular mass NUM NUM  NUMk    [rbapNUM]   [SEP][CLS] two lines of evidence support the notion that  [rbapNUM] and  [simian virus NUM t antigen] have homologous  [rb] binding properties  first  several mutated  [rb] proteins that failed to bind to t also did not associate with  [rbapNUM]  and second  both t antigen and t peptide  amino acids NUM NUM  were able to compete with  [rbapNUM] for binding to  [rb]  [SEP][CLS] the apparent targeting of the  [rbapNUM]  [rb] interaction by oncoproteins of dna tumour viruses strongly suggests that formation of this complex is functionally important  [SEP]$ protein_info=={sv40 t antigen;[0]}{retinoblastoma;[1]}{retinoblastoma susceptibility gene;[2]}{rb;[3, 4, 8, 9, 12, 14]}{rbap46;[5, 6, 10, 11, 13]}{simian virus 40 t antigen;[7]}$ pairs_info=={SV40 T antigen;retinoblastoma;false;1;0}{retinoblastoma susceptibility gene;Rb;false;1;0}{Rb;RbAP46;true;9;2}{RbAP46;simian virus 40 T antigen;false;3;0}{simian virus 40 T antigen;Rb;true;2;1}$
article_seq==355$ sen_num==6$ article_text==[CLS] evidence for a differential interaction of  [shc] and the  [insulin receptor substrate NUM]   [irs NUM]  with the  [insulin like growth factor i  igf i  receptor] in the yeast two hybrid system  [SEP][CLS] using the yeast two hybrid system  a genetic assay for studying protein protein interactions  we have examined and compared the interaction of the  [insulin like growth factor i receptor]   [igf ir]  and the  [insulin receptor]   [ir]  with their two known substrates  [pNUMshc] and the  [insulin receptor substrate NUM]   [irs NUM]   [SEP][CLS] we also mapped the specific domains of the  [igf ir] and  [pNUMshc] participating in these interactions  [SEP][CLS] our findings can be summarized as follows   i  the tyrosine kinase activity of the  [igf ir] is essential for the interaction with  [pNUMshc] and  [irs NUM]   ii   [pNUMshc] and  [irs NUM] bind to the  [igf ir] in the npey juxtamembrane motif   iii  contrary to  [pNUMshc]   [irs NUM] binds also to the major autophosphorylation sites  tyr NUM   NUM  and  NUM  of the  [igf ir]  and  iv  the amino terminal domain of  [pNUMshc] is required for its association with the  [ir] and the  [igf ir]  [SEP][CLS] we propose that  i  the  [igf ir] and the  [ir] share at least in part the same molecular mechanism underlying their interplay with their two substrates   [pNUMshc] and  [irs NUM]  and  ii   [irs NUM] interacts with the  [igf ir] in a fashion that is different from that used by  [pNUMshc]  [SEP][CLS] finally  our data highlight the crucial role of the juxtamembrane domain in signaling by both the  [ir] and the  [igf ir]  [SEP]$ protein_info=={shc;[0]}{insulin receptor substrate-1;[1, 9]}{irs-1;[2, 10, 15, 17, 20, 28, 29]}{insulin-like growth factor-i (igf-i) receptor;[3]}{insulin-like growth factor-i receptor;[4]}{igf-ir;[5, 11, 13, 18, 21, 24, 25, 30, 33]}{insulin receptor;[6]}{ir;[7, 23, 26, 32]}{p52shc;[8, 12, 14, 16, 19, 22, 27, 31]}$ pairs_info=={SHC;insulin receptor substrate-1;false;1;0}{SHC;IRS-1;false;1;0}{SHC;insulin-like growth factor-I (IGF-I) receptor;false;1;0}{insulin receptor substrate-1;IRS-1;false;2;0}{insulin receptor substrate-1;insulin-like growth factor-I (IGF-I) receptor;true;0;1}{IRS-1;insulin-like growth factor-I (IGF-I) receptor;true;0;1}{insulin-like growth factor-I receptor;IGF-IR;false;1;0}{insulin-like growth factor-I receptor;insulin receptor;false;1;0}{insulin-like growth factor-I receptor;IR;false;1;0}{insulin-like growth factor-I receptor;p52Shc;true;0;1}{insulin-like growth factor-I receptor;insulin receptor substrate-1;true;0;1}{insulin-like growth factor-I receptor;IRS-1;true;0;1}{IGF-IR;insulin receptor;false;1;0}{IGF-IR;IR;false;8;0}{IGF-IR;p52Shc;true;16;6}{IGF-IR;insulin receptor substrate-1;true;0;1}{IGF-IR;IRS-1;true;11;6}{insulin receptor;IR;false;1;0}{insulin receptor;p52Shc;true;0;1}{insulin receptor;insulin receptor substrate-1;true;0;1}{insulin receptor;IRS-1;true;0;1}{IR;p52Shc;true;4;3}{IR;insulin receptor substrate-1;true;0;1}{IR;IRS-1;true;4;2}{p52Shc;insulin receptor substrate-1;false;1;0}{p52Shc;IRS-1;false;17;0}$
article_seq==41$ sen_num==1$ article_text==[CLS] for the calibration  we used two sets of proteins  the  [myc]  [max]  [mxiNUM] helix loop helix proteins  and wild type and dimerization defective versions of the lambda ci repressor  [SEP]$ protein_info=={myc;[0]}{max;[1]}{mxi1;[2]}$ pairs_info=={Myc;Max;false;1;0}{Myc;Mxi1;false;1;0}{Max;Mxi1;false;1;0}$
article_seq==98$ sen_num==3$ article_text==[CLS] interaction of the protein  [nucleobindin] with  [g alpha iNUM]  as revealed by the yeast two hybrid system  [SEP][CLS] the specificity of intehraction between  [g alpha iNUM] and  [nucleobindin] was confirmed by an in vitro binding assay using recombinant proteins  [SEP][CLS] transfection of  [g alpha iNUM] and  [nucleobindin] in cos cells increased  [g alpha iNUM] expression relative to cells transfected with  [g alpha iNUM] and mock vector  [SEP]$ protein_info=={nucleobindin;[0, 3, 5]}{g alpha i2;[1, 2, 4, 6, 7]}$ pairs_info=={nucleobindin;G alpha i2;true;3;2}$
article_seq==129$ sen_num==5$ article_text==[CLS]  [rafNUM] interaction with  [cdcNUM phosphatase] ties mitogenic signal transduction to cell cycle activation  [SEP][CLS] the  [ras] and  [rafNUM] proto oncogenes transduce extracellular signals that promote cell growth  [SEP][CLS] we show here that  [cdcNUM phosphatase] associates with  [rafNUM] in somatic mammalian cells and in meiotic frog oocytes  [SEP][CLS] furthermore   [cdcNUM phosphatase] can be activated in vitro in a  [rafNUM] dependent manner  [SEP][CLS] we suggest that activation of the cell cycle by the  [ras]  [rafNUM] pathways might be mediated in part by  [cdcNUM]  [SEP]$ protein_info=={raf1;[0, 3, 5, 7, 9]}{cdc25 phosphatase;[1, 4, 6]}{ras;[2, 8]}{cdc25;[10]}$ pairs_info=={Raf1;Cdc25 phosphatase;true;0;3}{Ras;Raf1;false;2;0}{Ras;Cdc25;false;1;0}{Raf1;Cdc25;false;1;0}$
article_seq==376$ sen_num==9$ article_text==[CLS] a direct interaction between  [g protein beta gamma] subunits and the  [raf NUM protein kinase]  [SEP][CLS]  [raf NUM] is a serine threonine protein kinase positioned downstream of  [ras] in the  [mitogen activated protein kinase] cascade  [SEP][CLS] using a yeast two hybrid strategy to identify other proteins that interact with and potentially regulate  [raf NUM]  we isolated a clone encoding the carboxyl terminal half of the  [g beta NUM subunit] of heterotrimeric g proteins  [SEP][CLS] in vitro  purified  [g beta gamma] subunits specifically bound to a gst fusion protein encoding amino acids NUM NUM of  [raf NUM]   [raf NUM]   [SEP][CLS] binding assays with truncation mutants of gst  [raf] indicate that the region located between amino acids NUM and NUM is a primary determinant for interaction with  [g beta gamma]  [SEP][CLS] in competition experiments  the carboxyl terminus of  [beta adrenergic receptor kinase]   [beta ark]  blocked the binding of  [g beta gamma] to  [raf NUM]  however  the  [raf NUM] binding proteins   [ras] and NUM NUM NUM  had no effect  [SEP][CLS] scatchard analysis of in vitro binding between  [raf NUM] and  [g beta gamma] revealed an affinity of interaction  kd   NUM     NUM nm   similar to that seen between  [g beta gamma] and  [beta ark]  kd   NUM     NUM nm   [SEP][CLS] the formation of native heterotrimeric  [g alpha beta gamma] complexes  as measured by pertussis toxin adp ribosylation of g alpha  could be disrupted by increasing amounts of  [raf NUM]  with an ecNUM of approximately NUM nm  in close agreement with the estimated binding affinity  [SEP][CLS] in vivo complexes of  [raf NUM] and  [g beta gamma] were isolated from human embryonic kidney NUM t cells transfected with epitope tagged  [g beta NUM]  [SEP]$ protein_info=={g-protein beta gamma;[0]}{raf-1 protein kinase;[1]}{raf-1;[2, 5, 8, 16, 24]}{ras;[3, 17]}{mitogen-activated protein kinase;[4]}{g beta 2 subunit;[6]}{g beta gamma;[7, 11, 14, 19, 20, 25]}{raf/330;[9, 15, 18, 23]}{raf;[10]}{beta-adrenergic receptor kinase;[12]}{beta ark;[13, 21]}{g alpha beta gamma;[22]}{g beta 2;[26]}$ pairs_info=={G-protein beta gamma;Raf-1 protein kinase;true;0;1}{Raf-1;Ras;true;1;1}{Raf-1;mitogen-activated protein kinase;false;1;0}{Ras;mitogen-activated protein kinase;false;1;0}{Raf-1;G beta 2 subunit;true;0;1}{G beta gamma;Raf-1;true;1;2}{G beta gamma;Raf/330;true;1;3}{Raf-1;Raf/330;false;2;0}{Raf;G beta gamma;false;1;0}{beta-adrenergic receptor kinase;beta ARK;false;1;0}{beta-adrenergic receptor kinase;G beta gamma;false;1;0}{beta-adrenergic receptor kinase;Raf/330;false;1;0}{beta-adrenergic receptor kinase;Raf-1;false;1;0}{beta-adrenergic receptor kinase;Ras;false;1;0}{beta ARK;G beta gamma;true;2;1}{beta ARK;Raf/330;false;2;0}{beta ARK;Raf-1;false;1;0}{beta ARK;Ras;false;1;0}{G beta gamma;Ras;false;1;0}{Raf/330;Ras;false;1;0}{G alpha beta gamma;Raf/330;false;1;0}{Raf-1;G beta 2;false;1;0}{G beta gamma;G beta 2;false;1;0}$
article_seq==324$ sen_num==9$ article_text==[CLS] mutagenesis of the regulatory subunit   [rii beta]  of  [camp dependent protein kinase ii beta] reveals hydrophobic amino acids that are essential for  [rii beta] dimerization and or anchoring  [rii beta] to the cytoskeleton  [SEP][CLS] in neurons  [camp dependent protein kinase ii beta]   [pkaii beta]  is sequestered in the dendritic cytoskeleton because the regulatory subunit   [rii beta]  of the enzyme is tightly bound by a kinase anchor proteins  akaps   [SEP][CLS] the prototypic neuronal anchor protein  [akapNUM] has a cooh terminal NUM residue  [rii beta] binding  tethering  site  [SEP][CLS] mutagenesis  recombinant protein expression  and physicochemical characterization were used to investigate the structural basis for the homodimerization and  [akapNUM] binding activities of  [rii beta]  [SEP][CLS] substitution of ala for leuNUM or pheNUM generates monomeric  [rii beta] subunits that cannot bind  [akapNUM]  [SEP][CLS] the results are not due to general misfolding since mutant  [rii beta] monomers bind camp and inhibit the catalytic subunit of  [pkaii beta] with the same affinity and efficacy as wild type  [rii beta] dimers  [SEP][CLS] a secondary consequence of destabilizing  [rii beta] dimers is the loss of intracellular targeting anchoring capacity because monomers fail to bind  [akapNUM]  [SEP][CLS] other nhNUM terminal residues directly modulate the affinity of  [rii beta] dimers for the  [akapNUM] tethering site  [SEP][CLS] replacement of valNUM leuNUM with ala ala produced a dimeric  [rii beta] protein that binds  [akapNUM] approximately NUM  as avidly as wild type  [rii beta]  [SEP]$ protein_info=={rii beta;[0, 2, 3, 6, 8, 10, 11, 13, 15, 16, 18, 20, 22]}{camp-dependent protein kinase ii beta;[1, 4]}{pkaii beta;[5, 14]}{akap75;[7, 9, 12, 17, 19, 21]}$ pairs_info=={RII beta;cAMP-dependent protein kinase II beta;false;4;0}{cAMP-dependent protein kinase II beta;PKAII beta;false;1;0}{PKAII beta;RII beta;false;3;0}{AKAP75;RII beta;true;3;4}$
article_seq==191$ sen_num==6$ article_text==[CLS]  [jnkNUM]  a protein kinase stimulated by uv light and  [ha ras] that binds and phosphorylates the  [c jun] activation domain  [SEP][CLS] the ultraviolet  uv  response of mammalian cells is characterized by a rapid and selective increase in gene expression mediated by  [ap NUM] and  [nf kappa b]  [SEP][CLS] the effect on  [ap NUM] transcriptional activity results  in part  from enhanced phosphorylation of the  [c jun] nhNUM terminal activation domain  [SEP][CLS] here  we describe the molecular cloning and characterization of  [jnkNUM]  a distant relative of the  [map kinase] group that is activated by dual phosphorylation at thr and tyr during the uv response  [SEP][CLS] significantly   [ha ras] partially activates  [jnkNUM] and potentiates the activation caused by uv  [SEP][CLS]  [jnkNUM] binds to the  [c jun] transactivation domain and phosphorylates it on ser NUM and ser NUM  [SEP]$ protein_info=={jnk1;[0, 7, 10, 11]}{ha-ras;[1, 9]}{c-jun;[2, 6, 12]}{ap-1;[3, 5]}{nf-kappa b;[4]}{map kinase;[8]}$ pairs_info=={JNK1;Ha-Ras;true;1;1}{JNK1;c-Jun;true;0;2}{Ha-Ras;c-Jun;false;1;0}{AP-1;NF-kappa B;false;1;0}{AP-1;c-Jun;false;1;0}{JNK1;MAP kinase;false;1;0}$
article_seq==193$ sen_num==5$ article_text==[CLS]  [bNUM] is a ligand for the  [eck receptor protein tyrosine kinase]  [SEP][CLS] a protein ligand for the  [eck receptor protein tyrosine kinase] has been isolated by using the extracellular domain   [eck] x  of the receptor as an affinity reagent  [SEP][CLS] subsequently  supernatants from selected cell lines were fractionated directly by receptor affinity chromatography  resulting in the single step purification of  [bNUM]  a protein previously identified as the product of an early response gene induced by  [tumour necrosis factor alpha]  [SEP][CLS] we report here that recombinant  [bNUM] induces autophosphorylation of  [eck] in intact cells  consistent with  [bNUM] being an authentic ligand for  [eck]  [SEP][CLS]  [eck] is a member of a large orphan receptor protein tyrosine kinase family headed by eph  and we suggest that ligands for other members of this family will be related to  [bNUM]  and can be isolated in the same way  [SEP]$ protein_info=={b61;[0, 4, 6, 8, 11]}{eck receptor protein-tyrosine kinase;[1, 2]}{eck;[3, 7, 9, 10]}{tumour necrosis factor-alpha;[5]}$ pairs_info=={B61;ECK receptor protein-tyrosine kinase;true;0;1}{ECK receptor protein-tyrosine kinase;ECK;false;1;0}{B61;tumour necrosis factor-alpha;false;1;0}{B61;ECK;true;3;2}$
article_seq==118$ sen_num==4$ article_text==[CLS]  [cdiNUM]  a human gNUM and s phase protein phosphatase that associates with  [cdkNUM]  [SEP][CLS] we used the interaction trap  a yeast genetic selection for interacting proteins  to isolate human  [cyclin dependent kinase interactor NUM]   [cdiNUM]   [SEP][CLS] in yeast   [cdiNUM] interacts with cyclin dependent kinases  including human  [cdcNUM]   [cdkNUM]  and  [cdkNUM]  but not with  [cdkNUM]  [SEP][CLS] in hela cells   [cdiNUM] is expressed at the gNUM to s transition  and the protein forms stable complexes with  [cdkNUM]  [SEP]$ protein_info=={cdi1;[0, 3, 4, 9]}{cdk2;[1, 6, 10]}{cyclin-dependent kinase interactor 1;[2]}{cdc2;[5]}{cdk3;[7]}{cdk4;[8]}$ pairs_info=={Cdi1;Cdk2;true;0;3}{cyclin-dependent kinase interactor 1;Cdi1;false;1;0}{Cdi1;Cdc2;true;0;1}{Cdi1;Cdk3;true;0;1}{Cdi1;Cdk4;false;1;0}{Cdc2;Cdk2;false;1;0}{Cdc2;Cdk3;false;1;0}{Cdc2;Cdk4;false;1;0}{Cdk2;Cdk3;false;1;0}{Cdk2;Cdk4;false;1;0}{Cdk3;Cdk4;false;1;0}$
article_seq==386$ sen_num==10$ article_text==[CLS] the shNUM shNUM domain containing protein  [grbNUM] interacts with tyrosine phosphorylated  [irsNUM] and  [shc]  implications for insulin control of  [ras] signalling  [SEP][CLS]  [grbNUM]  a small protein comprising one shNUM domain and two shNUM domains  represents the human homologue of the caenorhabditis elegans protein   [sem NUM]  [SEP][CLS] both  [grbNUM] and  [sem NUM] have been implicated in a highly conserved mechanism that regulates  [pNUMras] signalling by receptor tyrosine kinases  [SEP][CLS] in this report we show that in response to  [insulin]   [grbNUM] forms a stable complex with two tyrosine phosphorylated proteins  [SEP][CLS] one protein is the major insulin receptor substrate  [irs NUM] and the second is the shNUM domain containing oncogenic protein   [shc]  [SEP][CLS] the interactions between  [grbNUM] and these two proteins require ligand activation of the  [insulin receptor] and are mediated by the binding of the shNUM domain of  [grbNUM] to phosphotyrosines on both  [irs NUM] and  [shc]  [SEP][CLS] although  [grbNUM] associates with  [irs NUM] and  [shc]  it is not tyrosine phosphorylated after  [insulin] stimulation  implying that  [grbNUM] is not a substrate for the insulin receptor  [SEP][CLS] furthermore  we have identified a short sequence motif  yv in  present in  [irs NUM]   [egfr] and  [shc]  which specifically binds the shNUM domain of  [grbNUM] with high affinity  [SEP][CLS] interestingly  both  [grbNUM] and  [phosphatidylinositol NUM  pi NUM  kinase] can simultaneously bind distinct tyrosine phosphorylated regions on the same  [irs NUM] molecule  suggesting a mechanism whereby  [irs NUM] could provide the core for a large signalling complex  [SEP][CLS] we propose a model whereby insulin stimulation leads to formation of multiple protein  protein interactions between  [grbNUM] and the two targets  [irs NUM] and  [shc]  [SEP]$ protein_info=={grb2;[0, 4, 6, 10, 13, 15, 18, 22, 26, 27, 31]}{irs1;[1]}{shc;[2, 12, 17, 20, 25, 33]}{ras;[3]}{sem-5;[5, 7]}{p21ras;[8]}{insulin;[9, 21]}{irs-1;[11, 16, 19, 23, 29, 30, 32]}{insulin receptor;[14]}{egfr;[24]}{phosphatidylinositol-3 (pi-3) kinase;[28]}$ pairs_info=={GRB2;IRS1;true;0;1}{GRB2;Shc;true;2;5}{GRB2;ras;false;1;0}{IRS1;Shc;false;1;0}{IRS1;ras;false;1;0}{Shc;ras;false;1;0}{GRB2;sem-5;false;2;0}{GRB2;p21ras;false;1;0}{sem-5;p21ras;false;1;0}{insulin;GRB2;false;3;0}{IRS-1;Shc;false;5;0}{GRB2;insulin receptor;false;2;0}{GRB2;IRS-1;true;3;5}{insulin receptor;IRS-1;false;1;0}{insulin receptor;Shc;false;1;0}{IRS-1;insulin;false;1;0}{Shc;insulin;false;1;0}{IRS-1;EGFR;false;1;0}{EGFR;Shc;false;1;0}{EGFR;GRB2;true;0;1}{GRB2;phosphatidylinositol-3 (PI-3) kinase;false;1;0}{phosphatidylinositol-3 (PI-3) kinase;IRS-1;true;1;1}$
article_seq==99$ sen_num==2$ article_text==[CLS] molecular studies of the multiprotein  [tfiid] complex have identified a primary  [tata binding subunit]   [tbp]   tbp associated factors  tafs  that interact with and mediate the function of activators and intersubunit interactions but have yielded relatively little insight into the structural organization of the complex or the actual mechanism of transcriptional activation  [SEP][CLS] here we present biochemical evidence for the structural relevance of histone homologies in the human  [tfiid] subunits  [htafNUM]   [htafNUM] and  [htafNUM NUM]  [SEP]$ protein_info=={tfiid;[0, 3]}{tata binding subunit;[1]}{tbp;[2]}{htaf80;[4]}{htaf31;[5]}{htaf20/15;[6]}$ pairs_info=={TFIID;TATA binding subunit;false;1;0}{TFIID;TBP;false;1;0}{TATA binding subunit;TBP;false;1;0}{TFIID;hTAF80;false;1;0}{TFIID;hTAF31;false;1;0}{TFIID;hTAF20/15;false;1;0}{hTAF80;hTAF31;false;1;0}{hTAF80;hTAF20/15;false;1;0}{hTAF31;hTAF20/15;false;1;0}$
article_seq==201$ sen_num==6$ article_text==[CLS]  [irak]  a kinase associated with the  [interleukin NUM receptor]  [SEP][CLS] the pleiotropic biological activities of  [interleukin NUM]   [il NUM]  are mediated by its type i receptor   [il NUMri]   [SEP][CLS] when the ligand binds   [il NUMri] initiates a signaling cascade that results in the activation of the transcription regulator  [nuclear factor kappa b]   [nf kappa b]   [SEP][CLS] a protein kinase designated  [irak]   [il NUM] receptor associated kinase  was purified  and its complementary dna was molecularly cloned  [SEP][CLS] when human embryonic kidney cells  cell line NUM  over expressing  [il NUMri] or hela cells were exposed to  [il NUM]   [irak] rapidly associated with the  [il NUMri] complex and was phosphorylated  [SEP][CLS] the primary amino acid sequence of  [irak] shares similarity with that of pelle a protein kinase that is essential for the activation of a  [nf kappa b] homolog in drosophila  [SEP]$ protein_info=={irak;[0, 8, 12, 14]}{interleukin-1 receptor;[1]}{interleukin-1;[2]}{il-1;[3, 9, 11]}{il-1ri;[4, 5, 10, 13]}{nuclear factor kappa b;[6]}{nf-kappa b;[7, 15]}$ pairs_info=={IRAK;interleukin-1 receptor;true;0;1}{interleukin-1;IL-1;false;1;0}{interleukin-1;IL-1RI;true;0;1}{IL-1;IL-1RI;true;2;1}{IL-1RI;nuclear factor kappa B;false;1;0}{IL-1RI;NF-kappa B;false;1;0}{nuclear factor kappa B;NF-kappa B;false;1;0}{IRAK;IL-1;false;2;0}{IL-1RI;IRAK;true;1;1}{IRAK;NF-kappa B;false;1;0}$
article_seq==95$ sen_num==2$ article_text==[CLS] the phagocyte  [nadph oxidase] is a complex of membrane  [cytochrome bNUM]  comprised of subunits  [pNUM phox] and  [gpNUM phox]  and three cytosol proteins   [pNUM phox]   [pNUM phox]  and  [pNUMrac]  that translocate to membrane and bind to  [cytochrome bNUM]  [SEP][CLS] this is the first report to demonstrate that two of cytosolic components of  [cytochrome bNUM]   [pNUM phox] binding to  [pNUM phox] each other  [SEP]$ protein_info=={nadph oxidase;[0]}{cytochrome b558;[1, 7, 8]}{p22-phox;[2]}{gp91-phox;[3]}{p47-phox;[4, 9]}{p67-phox;[5, 10]}{p21rac;[6]}$ pairs_info=={NADPH oxidase;cytochrome b558;false;2;0}{NADPH oxidase;p22-phox;false;1;0}{NADPH oxidase;gp91-phox;false;1;0}{NADPH oxidase;p47-phox;false;1;0}{NADPH oxidase;p67-phox;false;1;0}{NADPH oxidase;p21rac;false;1;0}{cytochrome b558;p22-phox;false;2;0}{cytochrome b558;gp91-phox;false;2;0}{cytochrome b558;p47-phox;true;2;1}{cytochrome b558;p67-phox;true;2;1}{cytochrome b558;p21rac;true;1;1}{p22-phox;gp91-phox;true;0;1}{p22-phox;p47-phox;false;1;0}{p22-phox;p67-phox;false;1;0}{p22-phox;p21rac;false;1;0}{gp91-phox;p47-phox;false;1;0}{gp91-phox;p67-phox;false;1;0}{gp91-phox;p21rac;false;1;0}{p47-phox;p67-phox;true;0;2}{p47-phox;p21rac;false;1;0}{p67-phox;p21rac;false;1;0}$
article_seq==267$ sen_num==7$ article_text==[CLS] in vitro and in nonproliferating cells   [pNUM] associates with and inhibits cyclin cycin dependent kinase  cdk  holoenzymes containing either  [cdkNUM]   [cdkNUM]  or  [cdkNUM]  [SEP][CLS] in addition   [pNUM] associates with three different cdks   [cdkNUM]   [cdkNUM]  and  [cdkNUM]  [SEP][CLS] furthermore  the amount of  [pNUM] is significantly lower than the amount of  [cyclin dNUM] in these cells  [SEP][CLS] the amount of  [cdkNUM] and  [cdkNUM] associated with  [pNUM] does not change in a cell cycle dependent fashion  in contrast  the amount of  [cdkNUM] associated with  [pNUM] is lowest in early gNUM cells and increases to a maximum in mid gNUM phase  reaching a steady state level in late gNUM phase cells  [SEP][CLS] the substrate specificity  the expression pattern of this kinase  and the ability to deplete NUM  of this kinase activity with a  [cdkNUM] specific antibody suggest that the  [cdkNUM] protein mediates  in part  the  [pNUM] associated  [rb] kinase activity  [SEP][CLS] in contrast   [pNUM] complexes containing  [cdkNUM] are incapable of phosphorylating  [histone hNUM]  [SEP][CLS] these data are consistent with a model wherein  [cyclin d] cdk complexes sequester the  [cdkNUM] dependent kinase inhibitory activity of  [pNUM]  [SEP]$ protein_info=={p27;[0, 4, 8, 12, 14, 17, 19, 24]}{cdk4;[1, 6, 10]}{cdk6;[2, 7, 11, 15, 16]}{cdk2;[3, 5, 13, 20, 23]}{cyclin d3;[9]}{rb;[18]}{histone h1;[21]}{cyclin d;[22]}$ pairs_info=={p27;CDK4;true;1;3}{p27;CDK6;true;3;3}{p27;CDK2;true;2;4}{CDK4;CDK6;false;3;0}{CDK4;CDK2;false;3;0}{CDK6;CDK2;false;3;0}{p27;cyclin D3;false;1;0}{CDK6;Rb;false;2;0}{p27;Rb;false;1;0}{p27;histone H1;false;1;0}{CDK2;histone H1;false;1;0}{cyclin D;CDK2;false;1;0}{cyclin D;p27;false;1;0}$
article_seq==250$ sen_num==6$ article_text==[CLS] structure of the  [pNUM] tumor suppressor bound to the ankyrin and shNUM domains of  [NUMbpNUM]  [SEP][CLS] the core domain contains the sequence specific dna binding activity and the in vitro  [NUMbpNUM] protein binding activity of  [pNUM]  [SEP][CLS] the crystal structure of the  [pNUM] core domain bound to the  [NUMbpNUM] protein  which contains an shNUM  src homology NUM  domain and four ankyrin repeats  revealed that  i  the shNUM domain binds the lNUM loop of  [pNUM] in a manner distinct from that of previously characterized shNUM polyproline peptide complexes  and  ii  an ankyrin repeat  which forms an l shaped structure consisting of a beta hairpin and two alpha helices  binds the lNUM loop of  [pNUM]  [SEP][CLS] the structure of the complex shows that the  [NUMbpNUM] binding site on the  [pNUM] core domain consists of evolutionarily conserved regions that are frequently mutated in cancer and that it overlaps the site of dna binding  [SEP][CLS] the six most frequently observed  [pNUM] mutations disrupt  [NUMbpNUM] binding in vitro  [SEP][CLS] the structure provides evidence that the  [NUMbpNUM]  [pNUM] complex forms in vivo and may have a critical role in the  [pNUM] pathway of tumor suppression  [SEP]$ protein_info=={p53;[0, 3, 4, 6, 7, 9, 10, 13, 14]}{53bp2;[1, 2, 5, 8, 11, 12]}$ pairs_info=={p53;53BP2;true;3;6}$
article_seq==185$ sen_num==4$ article_text==[CLS] we have cloned cdnas corresponding to the human  [interleukin NUM] receptor alpha chain   [il NUMralpha]   [SEP][CLS] only weak  [il NUM] binding activity was found in cells transfected with only  [il NUMralpha]  however  the combination of both  [il NUMralpha] and  [il NUMralpha] resulted in substantial binding activity  with a kd of approximately NUM pm  indicating that both chains are essential components of the  [il NUM] receptor  [SEP][CLS] whereas  [il NUMralpha] serves as an alternative accessory protein to the common  [cytokine receptor gamma chain]   [gammac]  for  [il NUM] signaling  it could not replace the function of  [gammac] in allowing enhanced  [il NUM] binding activity  [SEP][CLS] nevertheless  the overall size and length of the cytoplasmic domain of  [il NUMralpha] and  [gammac] are similar  and like  [gammac]   [il NUMralpha] is located on chromosome x  [SEP]$ protein_info=={interleukin 13;[0]}{il-13ralpha;[1, 3, 4, 7, 13, 16]}{il-13;[2, 6]}{il-4ralpha;[5]}{cytokine receptor gamma chain;[8]}{gammac;[9, 11, 14, 15]}{il-4;[10]}{il-2;[12]}$ pairs_info=={interleukin 13;IL-13Ralpha;false;1;0}{IL-13;IL-13Ralpha;true;3;1}{IL-13;IL-4Ralpha;false;2;0}{IL-13Ralpha;IL-4Ralpha;false;2;0}{IL-13Ralpha;cytokine receptor gamma chain;false;1;0}{IL-13Ralpha;gammac;false;6;0}{IL-13Ralpha;IL-4;true;0;1}{IL-13Ralpha;IL-2;false;1;0}{cytokine receptor gamma chain;gammac;false;2;0}{cytokine receptor gamma chain;IL-4;false;1;0}{cytokine receptor gamma chain;IL-2;false;1;0}{gammac;IL-4;false;2;0}{gammac;IL-2;false;2;0}{IL-4;IL-2;false;1;0}$
article_seq==105$ sen_num==3$ article_text==[CLS] in an unbiased search for potential coactivators of srebp  we isolated a protein of NUM kd from hela cells that directly bound  [srebp NUM] and  [srebp NUM]  [SEP][CLS] peptide sequencing and western blot analysis established that the NUM kd protein was  [cbp]   [creb binding protein]  a recently identified transcriptional coactivator  [SEP][CLS] the putative activation domain of srebp was shown to bind specifically to amino terminal domains of recombinant  [cbp] and  [pNUM]  a  [cbp] related protein   [SEP]$ protein_info=={srebp-1;[0]}{srebp-2;[1]}{cbp;[2, 4, 6]}{creb-binding protein;[3]}{p300;[5]}$ pairs_info=={SREBP-1;SREBP-2;false;1;0}{CBP;CREB-binding protein;false;1;0}{CBP;p300;false;2;0}$
article_seq==181$ sen_num==5$ article_text==[CLS] associations of  [ubeNUMi] with  [radNUM]   [ublNUM]   [pNUM]  and  [radNUM] proteins in a yeast two hybrid system  [SEP][CLS] using the human  [radNUM] protein as the  bait  in a yeast two hybrid system  we have identified a human homolog of yeast  [ubcNUM]  designated  [ubeNUMi]  that interacts with  [radNUM]   [radNUM]   [pNUM]  and a ubiquitin like protein  [ublNUM]  [SEP][CLS] these interactions are  [ubeNUMi] specific  since another dna repair related ubiquitin conjugating enzyme   [radNUM]   [ubcNUM]   does not interact with these proteins  [SEP][CLS] the interaction of  [ubeNUMi] with  [radNUM] is mediated by  [radNUM] s self association region  [SEP][CLS] these results suggest that the  [radNUM] dependent processes  cell cycle control   [pNUM] mediated pathway s   and ubiquitination interact through human  [ubeNUMi]  [SEP]$ protein_info=={ube2i;[0, 7, 12, 15, 20]}{rad52;[1, 5, 8, 16, 17, 18]}{ubl1;[2, 11]}{p53;[3, 10, 19]}{rad51;[4, 9]}{ubc9;[6]}{rad6;[13]}{ubc2;[14]}$ pairs_info=={UBE2I;RAD52;true;3;3}{UBE2I;UBL1;true;0;2}{UBE2I;p53;true;1;2}{UBE2I;RAD51;true;0;2}{RAD52;UBL1;false;3;0}{RAD52;p53;false;4;0}{RAD52;RAD51;false;3;0}{UBL1;p53;false;2;0}{UBL1;RAD51;false;2;0}{p53;RAD51;false;2;0}{RAD52;UBC9;false;2;0}{UBC9;UBE2I;false;1;0}{UBC9;RAD51;false;1;0}{UBC9;p53;false;1;0}{UBC9;UBL1;false;1;0}{UBE2I;RAD6;false;1;0}{UBE2I;UBC2;false;1;0}{RAD6;UBC2;false;1;0}$
article_seq==83$ sen_num==3$ article_text==[CLS] we now find that hiv NUM begins reverse transcription much more efficiently in dcs than t cells  even though t cells have higher levels of  [cdNUM] and  [gpNUM] binding  [SEP][CLS]  [rantes] interacts with  [ccrNUM] and  [sdf NUM] with  [cxcrNUM] receptors  [SEP][CLS] dcs express more  [ccrNUM] and  [cxcrNUM] mrna than t cells  [SEP]$ protein_info=={cd4;[0]}{gp120;[1]}{rantes;[2]}{ccr5;[3, 6]}{sdf-1;[4]}{cxcr4;[5, 7]}$ pairs_info=={CD4;gp120;false;1;0}{RANTES;CCR5;true;0;1}{RANTES;SDF-1;false;1;0}{RANTES;CXCR4;false;1;0}{CCR5;SDF-1;false;1;0}{CCR5;CXCR4;false;2;0}{SDF-1;CXCR4;true;0;1}$
article_seq==99$ sen_num==3$ article_text==[CLS] using epitope tagging  interaction of  [eNUM] basic helix loop helix protein with the  [eipNUM] protein encoded by this novel cdna was confirmed by immunoprecipitation experiments in cosNUM cells  [SEP][CLS] interactions with human  [parp] and mouse  [replication factor NUMa] were confirmed using glutathione transferase tagged cdnas  [SEP][CLS] a cdna encoding part of the  [nucleolin] protein sequence interacted with the  [eNUM] basic helix loop helix only when fused to a beta galactosidase tag  [SEP]$ protein_info=={e47;[0, 5]}{eip1;[1]}{parp;[2]}{replication factor 1a;[3]}{nucleolin;[4]}$ pairs_info=={E47;eip1;true;0;1}{PARP;replication factor 1a;false;1;0}{nucleolin;E47;true;0;1}$
article_seq==328$ sen_num==8$ article_text==[CLS]  [hepatitis b virus x protein] is a transcriptional modulator that communicates with  [transcription factor iib] and the  [rna polymerase ii subunit NUM]  [SEP][CLS]  [hepatitis b virus x protei]n   [hbx]  transactivates viral and cellular genes through a wide variety of cis elements  [SEP][CLS] our finding that  [hbx] directly interacts with  [rna polymerase ii subunit NUM]   [rpbNUM]   a common subunit of rna polymerases  implies that  [hbx] directly modulates the function of rna polymerase  cheong  j  h   yi  m   lin  y   and murakami  s   NUM  embo j  NUM  NUM NUM   [SEP][CLS] in this context  we examined the possibility that  [hbx] and  [rpbNUM] interact with other general transcription factors  [SEP][CLS]  [hbx] and  [rpbNUM] specifically bound to  [transcription factor iib]   [tfiib]  in vitro  both of which were detected by either far western blotting or the glutathione s transferase resin pull down assay  [SEP][CLS] delineation of the binding regions of these three proteins revealed that  [hbx]   [rpbNUM]  and  [tfiib] each has two binding regions for the other two proteins  [SEP][CLS] some  [hbx] substitution mutants  which had severely impaired transacting activity  exhibited reduced binding affinity with either  [tfiib] or  [rpbNUM] in a mutually exclusive manner  suggesting that  [hbx] transactivation requires the interactions of both  [rpbNUM] and  [tfiib]  [SEP][CLS] these results indicated that  [hbx] is a novel virus modulator that facilitates transcriptional initiation by stabilizing the association between rna polymerase and  [tfiib] through communication with  [rpbNUM] and  [tfiib]  [SEP]$ protein_info=={hepatitis b virus x protein;[0]}{transcription factor iib;[1, 13]}{rna polymerase ii subunit 5;[2, 6]}{hepatitis b virus x protei;[3]}{hbx;[4, 5, 8, 9, 11, 15, 18, 21, 24]}{rpb5;[7, 10, 12, 16, 20, 22, 26]}{tfiib;[14, 17, 19, 23, 25, 27]}$ pairs_info=={Hepatitis B virus X protein;transcription factor IIB;false;1;0}{Hepatitis B virus X protein;RNA polymerase II subunit 5;false;1;0}{transcription factor IIB;RNA polymerase II subunit 5;false;1;0}{Hepatitis B virus X protei;HBx;false;1;0}{HBx;RNA polymerase II subunit 5;true;1;1}{HBx;RPB5;true;6;4}{RNA polymerase II subunit 5;RPB5;false;1;0}{HBx;transcription factor IIB;false;1;0}{HBx;TFIIB;false;8;0}{RPB5;transcription factor IIB;false;1;0}{RPB5;TFIIB;false;8;0}{transcription factor IIB;TFIIB;false;1;0}$
article_seq==168$ sen_num==4$ article_text==[CLS] inflammation  regardless of whether it is provoked by infection or by tissue damage  starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines  [interleukin NUM]   [il NUM]  and  [tumour necrosis factor alpha]  ref  NUM   [SEP][CLS] three naturally occurring ligands for the  [il NUM receptor]   [ilNUMr]  exist  the agonists  [il NUMalpha] and  [il NUMbeta] and the  [il NUM receptor] antagonist  [ilNUMra]  ref  NUM   [SEP][CLS] here we describe the crystal structure at NUM NUM a resolution of the soluble extracellular part of  [type i ilNUMr] complexed with  [ilNUMra]  [SEP][CLS] a region that is important for biological function in  [il NUMbeta]  the  receptor trigger site  is not in direct contact with the receptor in the  [ilNUMra] complex  [SEP]$ protein_info=={interleukin-1;[0]}{il-1;[1]}{tumour necrosis factor-alpha;[2]}{il-1 receptor;[3]}{il1r;[4]}{il-1alpha;[5]}{il-1beta;[6, 11]}{il-1-receptor;[7]}{il1ra;[8, 10, 12]}{type-i il1r;[9]}$ pairs_info=={interleukin-1;IL-1;false;1;0}{interleukin-1;tumour necrosis factor-alpha;false;1;0}{IL-1;tumour necrosis factor-alpha;false;1;0}{IL-1 receptor;IL1R;false;1;0}{IL-1 receptor;IL-1alpha;true;0;1}{IL-1 receptor;IL-1beta;false;1;0}{IL-1 receptor;IL-1-receptor;false;1;0}{IL-1 receptor;IL1RA;false;1;0}{IL1R;IL-1alpha;false;1;0}{IL1R;IL-1beta;true;0;1}{IL1R;IL-1-receptor;false;1;0}{IL1R;IL1RA;false;1;0}{IL-1alpha;IL-1beta;false;1;0}{IL-1alpha;IL-1-receptor;false;1;0}{IL-1alpha;IL1RA;false;1;0}{IL-1beta;IL-1-receptor;false;1;0}{IL-1beta;IL1RA;false;2;0}{IL-1-receptor;IL1RA;true;0;1}{type-I IL1R;IL1RA;true;0;1}$
article_seq==222$ sen_num==8$ article_text==[CLS] cross family interaction between the bhlhzip  [usf] and bzip  [fraNUM] proteins results in down regulation of  [apNUM] activity  [SEP][CLS] a bzip protein   [fraNUM]  was found to efficiently interact with  [usf]  [SEP][CLS]  [usf] specifically interacts with  [fraNUM] but not with other closely related family members   [c fos]   [fraNUM]   [fosb]  or with  [c jun]  [SEP][CLS] both the bhlhzip and the n terminal regions of  [fraNUM] are required for efficient interaction with  [usf]  [SEP][CLS] in vivo association between  [usf] and  [fraNUM] has been demonstrated by co immunoprecipitation  [SEP][CLS] expression of exogenous  [usf] led to a decrease in  [apNUM] dependent transcription in fNUM cells  [SEP][CLS] co expression of exogenous  [fraNUM] restored the  [apNUM] activity in a dose dependent manner  [SEP][CLS] these data show that  [usf] and  [fraNUM] physically and functionally interact demonstrating that cross talk occurs between factors of distantly related transcription families  [SEP]$ protein_info=={usf;[0, 4, 5, 12, 13, 15, 19]}{fra1;[1, 3, 6, 11, 14, 17, 20]}{ap1;[2, 16, 18]}{c-fos;[7]}{fra2;[8]}{fosb;[9]}{c-jun;[10]}$ pairs_info=={USF;Fra1;true;0;6}{USF;AP1;false;2;0}{Fra1;AP1;false;2;0}{USF;c-Fos;false;1;0}{USF;Fra2;false;1;0}{USF;FosB;false;1;0}{USF;c-Jun;false;1;0}{Fra1;c-Fos;false;1;0}{Fra1;Fra2;false;1;0}{Fra1;FosB;false;1;0}{Fra1;c-Jun;false;1;0}{c-Fos;Fra2;false;1;0}{c-Fos;FosB;false;1;0}{c-Fos;c-Jun;false;1;0}{Fra2;FosB;false;1;0}{Fra2;c-Jun;false;1;0}{FosB;c-Jun;false;1;0}$
article_seq==217$ sen_num==6$ article_text==[CLS] interaction between  [atm] protein and  [c abl] in response to dna damage  [SEP][CLS] the gene mutated in the autosomal recessive disorder ataxia telangiectasia  at   designated  [atm]  for   [at mutated]    is a member of a family of phosphatidylinositol NUM kinase like enzymes that are involved in cell cycle control  meiotic recombination  telomere length monitoring and dna damage response  [SEP][CLS] because cells lacking the protein tyrosine kinase  [c abl] are also defective in radiation induced gNUM arrest  we investigated the possibility that  [atm] might interact with  [c abl] in response to radiation damage  [SEP][CLS] here we show that  [atm] binds  [c abl] constitutively in control cells but not in at cells  [SEP][CLS] our results demonstrate that the shNUM domain of  [c abl] interacts with a dpapnpphfp motif  residues NUM NUM NUM NUM  of  [atm]  [SEP][CLS] these findings indicate that  [atm] is involved in the activation of  [c abl] by dna damage and this interaction may in part mediate radiation induced gNUM arrest  [SEP]$ protein_info=={atm;[0, 2, 5, 7, 10, 11]}{c-abl;[1, 4, 6, 8, 9, 12]}{at mutated;[3]}$ pairs_info=={ATM;c-Abl;true;1;5}{ATM;AT mutated;false;1;0}$
article_seq==172$ sen_num==4$ article_text==[CLS] a region of the beta subunit of the  [interferon alpha receptor] different from box NUM interacts with  [jakNUM] and is sufficient to activate the  [jak] stat pathway and induce an antiviral state  [SEP][CLS] coexpression of the alpha and betal subunits of the human  [interferon alpha]   [ifnalpha]  receptor is required for the induction of an antiviral state by human  [ifnalpha]  [SEP][CLS] our results demonstrated that the first NUM amino acids  aas   aas NUM NUM  of the cytoplasmic domain of the betal chain are sufficient to activate the  [jak] stat pathway and trigger an antiviral state after  [ifnalphaNUM] binding to the receptor  [SEP][CLS] this region of the betal chain  required for  [jakNUM] binding and activation  contains the box NUM motif that is important for the interaction of some cytokine receptors with  [jak] kinases  [SEP]$ protein_info=={interferon alpha receptor;[0]}{jak1;[1, 8]}{jak;[2, 6, 9]}{interferon alpha;[3]}{ifnalpha;[4, 5]}{ifnalpha2;[7]}$ pairs_info=={interferon alpha receptor;Jak1;true;0;1}{interferon alpha receptor;Jak;false;1;0}{Jak1;Jak;false;2;0}{interferon alpha;IFNalpha;false;2;0}{Jak;IFNalpha2;false;1;0}$
article_seq==358$ sen_num==10$ article_text==[CLS] interaction between cell cycle regulator   [eNUMf NUM]  and  [nf kappab] mediates repression of hiv NUM gene transcription  [SEP][CLS] the  [nf kappab]  [rel] family of transcription factors is one of the main targets of cytokines and other agents that induce hiv NUM gene expression  [SEP][CLS] some of these extracellular stimuli arrest cells in the gNUM phase of the mitotic division cycle and modulate the activity of the tumor suppressor protein  [rb] and its partner  [eNUMf NUM]  [SEP][CLS] here  we demonstrate that  [eNUMf NUM] may regulate the activity of the hiv NUM long terminal repeat through its ability to bind sequences in the  [nf kappab] enhancer region and to interact with the  [nf kappab] subunit   [pNUM]  [SEP][CLS] gel retardation and methylation interference assays show that  [eNUMf NUM] is able to bind specifically to a site embedded within the two  [nf kappab] elements  [SEP][CLS] gel retardation immunoblot analysis using purified  [eNUMf NUM] and  [pNUM] homodimers reveals the presence of complexes containing both proteins  [SEP][CLS] affinity chromatography and co immunoprecipitation assays provide evidence for direct interaction of  [eNUMf NUM] and  [pNUM] in the absence of their dna target sequences  [SEP][CLS] in vitro transcription assay demonstrates that  [eNUMf NUM] represses  [nf kappab] mediated transcription in a cell free system  [SEP][CLS] functional studies in jurkat t lymphocytic cells point to the importance of both the  [eNUMf] and  [nf kappab] binding sites in  [eNUMf NUM] mediated repression of hiv NUM promoter  in vivo  [SEP][CLS] the results of this study suggest that  [nf kappab] activity may be regulated by its interaction with the cell cycle regulatory protein   [eNUMf NUM]  [SEP]$ protein_info=={e2f-1;[0, 5, 6, 10, 12, 14, 16, 20, 22]}{nf-kappab;[1, 2, 7, 8, 11, 17, 19, 21]}{rel;[3]}{rb;[4]}{p50;[9, 13, 15]}{e2f;[18]}$ pairs_info=={E2F-1;NF-kappaB;true;4;3}{NF-kappaB;Rel;false;1;0}{Rb;E2F-1;true;0;1}{E2F-1;p50;true;1;2}{NF-kappaB;p50;false;2;0}{E2F;NF-kappaB;false;1;0}{E2F;E2F-1;false;1;0}$
